Casdin Capital as of March 31, 2024
Portfolio Holdings for Casdin Capital
Casdin Capital holds 36 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 13.5 | $181M | 5.6M | 32.23 | |
| D Fluidigm Corp Del (LAB) | 12.5 | $168M | 62M | 2.71 | |
| Biolife Solutions Com New (BLFS) | 12.0 | $162M | 8.7M | 18.55 | |
| Sarepta Therapeutics (SRPT) | 10.3 | $138M | 1.1M | 129.46 | |
| Relay Therapeutics (RLAY) | 4.6 | $62M | 7.4M | 8.30 | |
| Alnylam Pharmaceuticals (ALNY) | 4.0 | $54M | 358k | 149.45 | |
| Avidity Biosciences Ord (RNA) | 4.0 | $53M | 2.1M | 25.52 | |
| Intellia Therapeutics (NTLA) | 3.9 | $53M | 1.9M | 27.51 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 3.6 | $48M | 1.1M | 42.86 | |
| EXACT Sciences Corporation (EXAS) | 3.3 | $45M | 650k | 69.06 | |
| Verve Therapeutics (VERV) | 3.0 | $41M | 3.1M | 13.28 | |
| Tenaya Therapeutics (TNYA) | 2.6 | $35M | 6.7M | 5.23 | |
| Illumina (ILMN) | 2.5 | $34M | 248k | 137.32 | |
| Blueprint Medicines (BPMC) | 2.3 | $31M | 326k | 94.86 | |
| Genedx Holdings Corp Com Cl A (WGS) | 2.1 | $29M | 3.1M | 9.13 | |
| Neurogene (NGNE) | 2.0 | $27M | 525k | 50.90 | |
| Denali Therapeutics (DNLI) | 2.0 | $27M | 1.3M | 20.52 | |
| 4d Molecular Therapeutics In (FDMT) | 1.9 | $26M | 800k | 31.86 | |
| Beam Therapeutics (BEAM) | 1.7 | $22M | 675k | 33.04 | |
| Veracyte (VCYT) | 1.4 | $19M | 858k | 22.16 | |
| Pliant Therapeutics (PLRX) | 1.1 | $15M | 1.0M | 14.90 | |
| Century Therapeutics (IPSC) | 1.0 | $13M | 3.2M | 4.18 | |
| 2seventy Bio Common Stock | 0.8 | $11M | 2.0M | 5.35 | |
| Abcellera Biologics (ABCL) | 0.8 | $11M | 2.4M | 4.53 | |
| Tango Therapeutics (TNGX) | 0.7 | $9.4M | 1.2M | 7.94 | |
| Codexis (CDXS) | 0.5 | $7.0M | 2.0M | 3.49 | |
| Absci Corp (ABSI) | 0.4 | $5.5M | 973k | 5.68 | |
| Pacific Biosciences of California (PACB) | 0.3 | $3.9M | 1.0M | 3.75 | |
| Kyverna Therapeutics (KYTX) | 0.3 | $3.7M | 150k | 24.84 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $3.6M | 511k | 7.05 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $3.6M | 150k | 23.80 | |
| Prime Medicine (PRME) | 0.2 | $2.6M | 367k | 7.00 | |
| Ginkgo Bioworks Holdings Cl A Shs | 0.1 | $1.7M | 1.5M | 1.16 | |
| Exscientia Ads (EXAI) | 0.1 | $1.2M | 214k | 5.72 | |
| Singular Genomics Systems In | 0.1 | $681k | 1.3M | 0.51 | |
| Kronos Bio | 0.0 | $161k | 124k | 1.30 |
